TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Decline In Breast Cancer Death Explained By Screening, Adjuvant Therapy, Study Finds November 25, 2005
TCL Archive High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer January 25, 2008